← Back to Search

Neurostimulation

Active tDCS for Acute Lymphoblastic Leukemia

N/A
Waitlist Available
Led By Tara Brinkman, PhD
Research Sponsored by St. Jude Children's Research Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline & 6-month follow-up
Awards & highlights

Study Summary

This trial is testing whether home-based transcranial direct current stimulation (tDCS) paired with remote cognitive training can help improve executive function in survivors of ALL.

Eligible Conditions
  • Acute Lymphoblastic Leukemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & 6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline & 6-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Direct Testing of Executive Function: Change in Cognitive Flexibility in baseline to 6 months
Direct Testing of Executive Function: Change in Verbal Fluency from baseline to 6 months
Direct Testing of Executive Function: Change in Working Memory from baseline to 6 months
Secondary outcome measures
Change in Brain Connectivity from baseline to 6 months
Change in Patient-Reported Symptoms of Executive Functioning from baseline to 6 months
Change in Regional Brian Activation from baseline to 6 months

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active tDCSActive Control1 Intervention
Remotely delivered active tDCS + cognitive training
Group II: Sham tDCSPlacebo Group1 Intervention
Remotely delivered sham tDCS + cognitive training

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,924,145 Total Patients Enrolled
St. Jude Children's Research HospitalLead Sponsor
428 Previous Clinical Trials
5,306,486 Total Patients Enrolled
Tara Brinkman, PhDPrincipal InvestigatorSt. Jude Children's Research Hospital
3 Previous Clinical Trials
1,388 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the qualifications for enrolment in this medical experiment?

"This clinical trial seeks 104 participants aged 18-39 with acute lymphoblastic leukemia, who have enrolled on the St. Jude's Lifetime Cohort Study, and whose treatment completed two years prior that could affect their central nervous system. Additional criteria include having an age-adjusted standard score <16th percentile on Trail Making Test Part B, Controlled Oral Word association Test, or Digit Span Backward as well as a standard score >84th percentile from either the Childhood Cancer Survivor Study Neurocognitive Questionnaire or Behavior Rating Scale of Executive Function."

Answered by AI

Are there opportunities for prospective participants to join this research project?

"According to clinicaltrials.gov, the recruiting process for this medical trial is still ongoing - with its initial posting taking place on December 12th 2019 and being amended most recently on October 28th 2022."

Answered by AI

To what extent is recruitment to this clinical trial proceeding?

"Yes, the data hosted on clinicaltrials.gov confirms that this research endeavour is presently recruiting participants. It was first announced in December 2019 and most recently updated at the end of October 2022; they are looking to enrol 104 individuals from a single site."

Answered by AI

Is there an age restriction for participants in this investigation?

"This research initiative is actively enrolling participants that are legally of age and younger than three decades old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)
2019. "Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04007601.
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top